Title : A gene expression profile indicative of early stage HER2 targeted therapy response.

Pub. Date : 2013 Jul 1

PMID : 23816254






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Treatment of HER2 TKI-sensitive SKBR3 and BT474 cell lines with lapatinib, afatinib and neratinib induced an increase in the expression of RB1CC1, ERBB3, FOXO3a and NR3C1. Lapatinib erb-b2 receptor tyrosine kinase 3 Homo sapiens